We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BIOM3 market cap is 2.04B. The company's latest EPS is BRL -0.7297 and P/E is -22.06.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 30.74M | 26.31M | 34.28M | 30.77M | 33.13M |
Operating Income | -23.62M | -21.41M | -15.39M | -18.51M | -19.9M |
Net Income | -25.14M | -22.29M | -17.93M | -20.22M | -21.93M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 1.57M | 8.94M | 58.67M | 107.09M | 104.95M |
Operating Income | -36.67M | -52.61M | -55.57M | -65.65M | -86.24M |
Net Income | -42.56M | -55.81M | -70.77M | -80.26M | -92.56M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 352.65M | 405.09M | 376M | 342.3M | 339.41M |
Total Liabilities | 231.29M | 245.98M | 234.83M | 221.37M | 240.39M |
Total Equity | 121.36M | 159.11M | 141.17M | 120.93M | 99.01M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 305.68M | 388.77M | 434.97M | 369.83M | 405.09M |
Total Liabilities | 199.59M | 235.21M | 243.49M | 258.25M | 245.98M |
Total Equity | 106.09M | 153.56M | 191.48M | 111.59M | 159.11M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | -49.71M | -63M | -33.6M | -45.07M | -57.31M |
Investing | -15.13M | -6.16M | 217k | 2.96M | 1.35M |
Financing | 50.6M | 113.79M | -4.17M | -9.79M | -222k |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | -44.12M | -80.85M | -96.87M | -93.78M | -63M |
Investing | -27.35M | -20.52M | -6.84M | 61.49M | -6.16M |
Financing | 78.66M | 110.65M | 130.85M | 7.42M | 113.79M |
Market Cap | 2.04B |
Price to Earnings Ratio | -22.06 |
Price to Sales Ratio | 19.46 |
Price to Cash Ratio | 26.9 |
Price to Book Ratio | 12.83 |
Dividend Yield | - |
Shares Outstanding | 126.84M |
Average Volume (1 week) | 225.12k |
Average Volume (1 Month) | 244.16k |
52 Week Change | 330.48% |
52 Week High | 18.40 |
52 Week Low | 3.65 |
Spread (Intraday) | 0.98 (5.95%) |
Company Name | Biomm SA |
Address |
praca carlos chagas n. 49, 8 andar belo horizonte, minas gerais 30170-020 |
Website | https://www.biomm.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions